APG Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.6M Sell
95,253
-12,658
-12% -$3.15M 0.06% 234
2025
Q4
$22.1M Sell
107,911
-5,804
-5% -$1.48M 0.06% 223
2025
Q3
$26.5M Sell
113,715
-2,024
-2% -$553K 0.07% 214
2025
Q2
$25.4M Buy
115,739
+3,363
+3% +$802K 0.08% 221
2025
Q1
$23.3M Sell
112,376
-12,379
-10% -$2.89M 0.07% 223
2024
Q4
$27.6M Buy
124,755
+81,643
+189% +$19.7M 0.08% 211
2024
Q3
$9.43M Sell
43,112
-99,439
-70% -$22.2M 0.06% 203
2024
Q2
$25.5M Buy
142,551
+42,332
+42% +$8.59M 0.05% 305
2024
Q1
$18.4M Sell
100,219
-7,853
-7% -$1.44M 0.03% 352
2023
Q4
$16.8M Sell
108,072
-5,744
-5% -$883K 0.03% 344
2023
Q3
$16.8M Sell
113,816
-14,260
-11% -$2.58M 0.03% 350
2023
Q2
$25.7M Sell
128,076
-2,325
-2% -$518K 0.05% 304
2023
Q1
$26.3M Sell
130,401
-21,963
-14% -$4.76M 0.06% 311
2022
Q4
$31.7M Buy
152,364
+124,586
+449% +$27.4M 0.06% 308
2022
Q3
$6.19M Buy
27,778
+7,570
+37% +$1.72M 0.02% 417
2022
Q2
$4.05M Buy
20,208
+13,408
+197% +$2.85M 0.01% 468
2022
Q1
$1.48M Sell
6,800
-5,600
-45% -$1.35M ﹤0.01% 617
2021
Q4
$2.84M Sell
12,400
-11,907
-49% -$3.09M ﹤0.01% 552
2021
Q3
$5.53M Buy
24,307
+9,007
+59% +$2.46M 0.01% 499
2021
Q2
$3.18M Sell
15,300
-5,300
-26% -$1.11M 0.01% 591
2021
Q1
$3.4M Sell
20,600
-116,423
-85% -$23.3M 0.01% 620
2020
Q4
$23.8M Buy
137,023
+14,384
+12% +$2.87M 0.04% 401
2020
Q3
$17.9M Sell
122,639
-51,664
-30% -$9.54M 0.03% 459
2020
Q2
$29.8M Sell
174,303
-58,404
-25% -$9.56M 0.05% 326
2020
Q1
$34.3M Buy
232,707
+67,906
+41% +$10.8M 0.07% 282
2019
Q4
$22.8M Buy
164,801
+11,200
+7% +$1.61M 0.04% 409
2019
Q3
$19M Buy
153,601
+86,244
+128% +$11.3M 0.03% 428
2019
Q2
$7.22M Buy
67,357
+11,600
+21% +$1.28M 0.01% 578
2019
Q1
$5.16M Sell
55,757
-82,016
-60% -$8.47M 0.01% 604
2018
Q4
$13.7M Buy
137,773
+43,100
+46% +$4.62M 0.03% 416
2018
Q3
$9.4M Buy
94,673
+15,800
+20% +$1.73M 0.02% 506
2018
Q2
$7M Sell
78,873
-4,100
-5% -$415K 0.01% 540
2018
Q1
$6.64M Sell
82,973
-600
-0.7% -$56.7K 0.01% 537
2017
Q4
$5.89M Buy
83,573
+898
+1% +$74.2K 0.01% 590
2017
Q3
$6.36M Sell
82,675
-222,683
-73% -$17M 0.01% 593
2017
Q2
$23.8M Sell
305,358
-60,967
-17% -$4.36M 0.04% 386
2017
Q1
$26.4M Sell
366,325
-70,575
-16% -$4.88M 0.05% 378
2016
Q4
$25.7M Buy
436,900
+21,000
+5% +$1.29M 0.05% 378
2016
Q3
$26.9M Hold
415,900
0.05% 389
2016
Q2
$26.3M Buy
415,900
+102,500
+33% +$6.04M 0.05% 365
2016
Q1
$18.1M Sell
313,400
-118,606
-27% -$6.71M 0.04% 413
2015
Q4
$23.2M Sell
432,006
-144,300
-25% -$8.13M 0.05% 351
2015
Q3
$29.4M Sell
576,306
-294,701
-34% -$15.9M 0.07% 318
2015
Q2
$49.1M Sell
871,007
-63,000
-7% -$3.98M 0.1% 254
2015
Q1
$67M Sell
934,007
-54,897
-6% -$3.57M 0.14% 192
2014
Q4
$55.4M Sell
988,904
-248,508
-20% -$13M 0.11% 233
2014
Q3
$61M Sell
1,237,412
-54,776
-4% -$2.79M 0.12% 207
2014
Q2
$65.4M Sell
1,292,188
-171,750
-12% -$8.51M 0.14% 197
2014
Q1
$65.4M Buy
1,463,938
+27,380
+2% +$1.23M 0.17% 159
2013
Q4
$67.6M Buy
1,436,558
+490,039
+52% +$24.8M 0.2% 148
2013
Q3
$50M Buy
946,519
+662,521
+233% +$32.1M 0.16% 173
2013
Q2
$12.8M Buy
+283,998
New +$13.5M 0.04% 418

Other funds holding RMD

APG Asset Management's RMD Position: Q1 2026 in Review

APG Asset Management reduced its ResMed (RMD) stake by 12% in Q1 2026, selling an estimated $3.15M and leaving 95,253 shares worth $18.6M. The position accounts for 0.06% of the portfolio, ranked #234.

APG Asset Management first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $67.6M in Q4 2013. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • APG Asset Management held 95,253 shares of ResMed worth $18.6M as of Q1 2026.
  • APG Asset Management sold 12,658 ResMed shares in Q1 2026, an estimated $3.15M.
  • ResMed made up 0.06% of APG Asset Management's portfolio in Q1 2026, its #234 holding.
  • APG Asset Management first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • APG Asset Management's ResMed position peaked at $67.6M in Q4 2013.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on APG Asset Management's 13F filing for Q1 2026, filed 13 May 2026.